MedTrace Logo

Observational Study on Cardiac Biomarkers Testing in Patients with Muscular Dystrophy Cardiomyopathy

NCT05779202 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2025-03-30

No results posted yet for this study

Summary

The objective of this study is to evaluate acute changes of cardiac troponin (and other cardiac biomarkers) and mid-term biovariability in patients with cardiomyopathy associated with chronic skeletal muscle disease. The specific aims of the study are:

Firstly, to evaluate the feasibility of the ESC 0/1 hour protocol for rule-in and rule-out of a non-ST-segment elevation acute coronary syndrome (NSTE-ACS).

Secondly, a) to determine reference change values (RCV) to characterize physiological biovariability, b) to differentiate acute from chronic high-sensitivity cardiac troponin T (hs-cTnT) elevations.

Conditions

  • Cardiomyopathies
  • Skeletal Muscle Disorder

Interventions

OTHER

No intervention is planned.

No intervention is planned.

Sponsors & Collaborators

  • University Hospital Heidelberg

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05779202 on ClinicalTrials.gov